Purification of RBF-2, a transcription factor with specificity for the most conserved cis-element of naturally occurring HIV-1 LTRs

Journal of Biomedical Science

Volumn 6, Issue 5, 1999, Pages 320-332

  Estable, Mario Clemente ^a,b   Hirst, Martin ^a   Bell, Brendan ^a   O'Shaughnessy, Michael V ^b   Sadowski, Ivan ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

HIV 1 LTR; RBF 2 purification; Transcription factor

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RBF 2; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; BINDING SITE; DNA BINDING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; ION EXCHANGE CHROMATOGRAPHY; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032857953     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02253521     Document Type: Article

References (43)

1. Ait-Khaled M, Emery VC. Phylogenetic relationship between human immunodeficiency virus type I (HIV-1) long terminal repeat natural variants present in the lymph node and peripheral blood of three HIV-1-infected individuals. J Gen Virol 75:1615-21;1994.
2. Ait-Khaled M. McLaughlin JE, Johnson MA, Emery VV. Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient. AIDS 9:675-683; 1995.
3. Alizon M, Wain-Hobson S, Montagnier E, Sonigo P. Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients. Cell 46:63-74;1986.
4. Bell B, Sadowski I. Ras-responsiveness of the HIV-1 ETR requires RBF-1 and RBF-2 binding sites. Oncogene 13:2687-2697;1996.
5. Bowdish KS, Yuan HE, Mitchel AP. Positive control of yeast meiotic genes by the negative regulator UME6. Mol Cell Biol 15:2955-2961; 1995.
6. Cheynier R, Henichwark S, Hadida F, Pelletier E, Oksenhendler E, Autran B, Wain-Hobson S. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 78:373-387;1994.
7. Cheynier R, Henrichwark S, Hadida F, Pelletier E, Oksenhendler E, Autran B, Wain-Hobson S. Clonal expansion of T cells and HIV genotypes in microdissected splenic white pulps indicates viral replication in situ and infiltration of HIV-specific cytotoxic T lymphocytes. Adv Exp Med Biol 374:173-182; 1995.
8. Coffin JM. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis and therapy. Science 267:483-489;1995.
9. Delassus S. Meyerhans A, Cheynier R, Wain-Hobson S. Absence of selection of HIV-1 variants in vivo based on transcription/transactivation during progression to AIDS. Virology 188: 811-818;1992.
10. Estable MC, Bell B, Hirst M, Sadowski IJ. Naturally occurring HIV-1 LTRs have a frequently observed duplication that binds RBF-2 and represses transcription. J Virol 72:6465-6474; 1998.
11. Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, Sadowski IJ. Human immunodeficiency virus type I long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 70:4053-4062;1996.
12. Estable MC, Merzouki A, Arella M, Sadowski IJ. Distinct clustering of HIV-1 sequences derived from injection drug users versus non-injection drug in users in Vancouver, Canada. AIDS Res Hum Relroviruses 14:917-919; 1998.
13. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 262:1011-1018;1993.
14. Flory E, Hoffmeyer A, Smola U, Rapp UR, Bruder JT. Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type I promoter. J Virol 70:2260-2268;1996.
15. Folguiera L, Algeciras A, McMorran WS, Bren GD, Paya CV. The Ras-Raf pathway is activated in human immunodeficiency virus infected monocytes and participates in the activation of NFΚB. J Virol 70:2332-2338;1996.
16. Goodenow M, Huet T, Saurin W, Kwok S, Shinsky J, Wain-Hobson S. HIV-1 isolates are rapidly evolving quasispecies: Evidence for viral mixtures and preferred nucleotide substitutions. J AIDS 2:344-352;1989.
17. Hellerstein MK, McCunes JM. T cell turnover in HIV-1 disease. Immunity 7:583-589;1997.
18. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126;1995.
19. Hughes SH, Shank PR, Spector DH, Kung HJ, Bishop JM, Varmus HE, Vogt PK, Breitman ML. Proviruses of avian sarcoma virus are terminally redundant, co-extensive with uninte-grated linear DNA and integrated at many sites. Cell 15:1397-1410;1978.
20. Jones KA, Peterlin BM. Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 63:717-743;1994.
21. Ju G, Skalka AM. Nucleotide sequence analysis of the long terminal repeat (LTR) of avian retroviruses: Structural similarities with transposable elements. Cell 22:379-386;1980.
22. Kadonaga JT. Purification of sequence-specific binding proteins by DNA affinity chromatography. Sauer RT, ed. Methods in Enzymology Protein-DNA Interactions. San Diego. Academic Press, vol 208, 10-23;1991.
23. Kadosh D, Struhl K. Repression by Ume6 involves recruitment of a complex containing Sin3 corpressor and Rpd3 histone deacetylase to target promoters. Cell 89:365-371;1997.
24. Koken SE, van Wamel JE, Goudsmit J. Berkhout B. Geelen JE. Natural variants of the HIV-1 long terminal repeat: Analysis of promoters with duplicated DNA regulatory motifs. Virology 191:968-972;1992.
25. Koken SE, VanWamel JE, Goudsmit J, Berkhout B. Geelen JE. Functional analysis of the ACTGCTGA sequence motif in the human immunodeficiency virus type-1 long terminal repeat promoter. J Biomed Sci 1:83-92;1994.
26. LaMarco K, Thompson CC, Byers BP, Walton EM, McKnight SE. Identification of Ets-and notch-related subunits in GA binding protein. Science 25:789-792;1991.
27. Meyerhans A, Cheynier R, Albert J. Seth M, Kwok S, Sninsky J, Morfeldt-Manson L, Asjo B, Wain-Hobson S. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58:901-910;1989.
28. Moodie SA, Wolfman A. The 3 Rs of life: Ras, Raf and growth regulation. Trends Genet 10: 44-48;1994.
29. Moretti P, Freeman K, Coodly L, Shore D. Evidence that a complex of SIR proteins interacts with the silencer and telomere-binding protein RAP1. Genes Dev 8:2257-2269;1994.
30. Myers G. Human Retroviruses and AIDS. Los Alamos, Los Alamos National Library, 1996.
31. Pantaleo G, Fauci AS. Immunopathogenesis of HIV infection. Annu Rev Microbiol 50:825-853;1996.
32. Rundlett SE, Carmen AA, Suka N, Turner BM, Grunstein M. Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3. Nature 392:831-835;1998.
33. Shank RP, Hughes SH, Kung HJ, Majors JE, Quintrell N, Guntaka RV, Bishoop JM, Varmus HE. Mapping unintegrated avian sarcoma virus DNA: Termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA. Cell 15:1383-1395;1978.
34. Shore D. RAP1: A protean regulator in yeast. Trends Genet 10:408-412;1994.
35. Taylor JM. DNA intermediates of avian RNA tumor viruses. Curr Top Microbiol Immuno 87:23-41;1979.
36. Thompson CC, Brown TA, McKnight SL. Convergence of Ets-and Notch-related motifs in a heteromeric DNA binding complex. Science 253:762-768;1991.
37. Treitel MA, Carlson M. Repression by SSN6-TUP1 is directed by MIG1, a repressor/activator protein. Proc Natl Acad Sci USA 92:3132-3136;1995.
38. Wain-Hobson S. Down or out in blood and lymph? Nature 387:123-124;1997.
39. Wain-Hobson S. Running the gamut of retroviral variation. Trends Microbiol 4:135-141; 1996.
40. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM. Viral dynamics in human immunodeficiency virus type I infection. Nature 373:117-122; 1995.
41. Yammamato T, deCrombrugghe B, Pastan I. Identification of a functional promoter in the long terminal repeat of Rous sarcoma virus. Cell 22:787-797;1980.
42. Zhang L, Huang Y, Yuan H, Chen BK, Ip J, HO DD. Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type I infection. J Virol 71:5608-5613;1997.
43. Zhang L, Huang Y, Yuan H, Chen BK, Ip J, Ho DD. Identification of a replication-competent pathogenic human immunodeficiency virus type I with a duplication in the TCF-1 alpha region but lacking NF-kappaB binding sites. J Virol 71:1651-1656;1997.